Springer) Springer, one of the leading publishers in the fields of science, technology and medicine, has signed a co-publishing agreement with the Indian Association of Surgical Oncology, to launch the society's official publication, the Indian Journal of Surgical Oncology.

Medical College of Georgia) Estrogen can halt stroke damage by inactivating a tumor-suppressing protein known to prevent many cancers, Medical College of Georgia researchers say.

Helmholtz Association of German Research Centres) Gliomas are among the most common and most malignant brain tumors. These tumors infiltrate normal brain tissue and grow very rapidly. As a result, surgery can never completely remove the tumor. Now, the neurosurgeons

Cold Spring Harbor Laboratory) An upcoming G&D paper reveals how two specific matrix metalloproteinase (MMP) proteins contribute to bone metastasis in advanced breast cancer -- lending important new insight into the design of clinically useful small molecule inhibitors.

Dartmouth-Hitchcock Medical Center) Dartmouth Medical School immunologists have devised a Trojan horse to help overcome ovarian cancer, unleashing a surprise killer in the surroundings of a hard-to-treat tumor.

Journal of the National Cancer Institute) Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer did not improve their survival but did increase their risk of blood clots, according to a new study published online July

UT Southwestern Medical Center) A new study by UT Southwestern Medical Center researchers sheds light on the challenges involved in identifying which high-risk population would benefit most from bladder-cancer screening.

University of Copenhagen) A team of scientists from the University of Copenhagen and the Max Planck Institute in Germany, has identified no less than 3,600 molecular switches in the human body. These switches, which regulate protein functions, may prove to

Washington University School of Medicine) Researchers at Washington University School of Medicine in St. Louis have shed new light on a process that fixes breaks in the genetic material of the body's cells. Their findings could lead to ways of

Public Library of Science) A new strategy proposed by researchers at Dartmouth Medical School and Amtek, Hannover, NH may treat tumors that do not respond to conventional treatment. The study, which was published on May 29 in the open-access, peer-reviewed

ECCO-the European CanCer Organisation) An initiative to boost cancer prevention, treatment and care throughout Europe by improving communications within the cancer community kicks off on Monday, July 20, with the launch of a new Web site. The project will involve

The Translational Genomics Research Institute) Carriers have nearly twice the risk of developing follicular lymphoma, according to cancer's first genome-wide association study.

Lifespan) Rhode Island Hospital is one of only four sites across the country to participate in a new clinical trial called the DIGNITY study. The study will investigate the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction with mild

American Friends of Tel Aviv University) The new drug compound Salirasib, developed at Tel Aviv University, has shown positive results against pancreatic cancer and recently passed Phase I/II clinical trials. The drug, given in combination with gemcitabine, the standard drug

JAMA and Archives Journals) Surgically removing and evaluating an increasing number of lymph nodes does not appear to identify a greater number of patients with stage III colorectal cancer, according to a report in the July issue of Archives of

University of Pittsburgh Schools of the Health Sciences) Successes in cancer treatment have created a challenge for young cancer patients since the chemotherapy and radiation treatments that save lives threaten fertility. At the annual meeting of the Society for the

American College of Physicians) Below is information about four studies being published in the July 21 issue of Annals of Internal Medicine. The information is not intended to substitute for articles as sources of information. Annals of Internal Medicine attribution

Journal of Clinical Investigation) Research has identified RCP as a new gene contributing to aggressive breast cancer behavior. Detailed analysis determined that one mechanism by which RCP promotes breast cancer is likely to be via activation of the RAS signaling

Journal of Clinical Investigation) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published July 20, 2009, in the JCI: Extending the life of an appetite-suppressing peptide; New breast cancer-promoting gene identified;

University of Rochester Medical Center) An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer.